drugset / Trial / NCT01535040
Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking
Phase 2
Completed
130 enrolled
Wake Forest University Health Sciences
National Cancer Institute (NCI) · collab
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
RATIONALE: Memantine hydrochloride may help people stop smoking by decreasing the symptoms of nicotine withdrawal. PURPOSE: This randomized, pilot phase II trial studies how effective memantine hydrochloride works compared to placebo in helping cancer survivors stop smoking.
Timeline
- Start
- 2012-08-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Memantine | Unknown | 10 mg | Oral |